retatrutide clinical trial obesity Retatrutide, an Amazing Future for Weight Loss Retatrutide Weight Loss Results:Trial Data

For instance, retatrutide trials typically enroll individuals with comorbid conditions such as hypertension or fatty liver and monitor additional endpoints such as knee pain

With recent FDA enforcement against misleading direct-to-consumer prescription drug advertising, telehealth and DTC platforms that advertise GLP-1 products will likely need more careful legal / regulatory oversight of their ad claims, especially around benefit claims and safety disclosures

10.1007/s00125-020-05213-5 9 KilimnikG.KimA.SteinerD

[DOI] [PubMed] [Google Scholar] 18.Montero A, Sparks G, Presiado M, Published LH

Weight loss tends to reverse when the drugs are stopped, and little is known about maintenance strategies such as lower doses or less frequent dosing

The receptors each compound targets determine its entire profile of benefits and limitations